Marc Lubin

Icahn School of Medicine at Mount Sinai, Maimonides Medical Center

Papers

Total Citations

H-Index

About

Marc Lubin is a urologic surgeon and researcher whose work focuses on advancing perioperative care in robotic urologic oncology. His primary research areas include opioid-sparing surgical protocols, enhanced recovery after surgery (ERAS), and the feasibility of same-day discharge for complex robotic procedures. Dr. Lubin’s major contribution is the prospective implementation of a nonopioid protocol for patients undergoing robot-assisted radical cystectomy with extracorporeal urinary diversion—a landmark study (34 citations) that demonstrated effective pain management without narcotics, reducing opioid-related complications in major cancer surgery. He also led a pivotal investigation into same-day discharge after robot-assisted partial nephrectomy (18 citations), evaluating both safety and cost-effectiveness, challenging traditional inpatient paradigms for kidney cancer surgery. This work has significant implications for reducing hospital stays and healthcare costs while maintaining patient outcomes. Dr. Lubin’s research is notable for its direct clinical translation, helping to shift practice toward more efficient, patient-centered recovery pathways. His contributions are increasingly cited as benchmarks in urologic oncology and perioperative innovation.